Rubicyt 50mg Injection
Marketer
Cytogen Pharmaceuticals India Pvt Ltd
Salt Composition
Epirubicin (50mg)
Overview Rubicyt 50mg Injection
Rubicyt 50mg Injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your physician, based on your condition and may vary. Strictly adhere to prescribed usage; incorrect or excessive administration can lead to severe adverse reactions. Benefits may not be immediately apparent; discontinue only under physician guidance. Note that it diminishes contraceptive efficacy; reliable birth control is recommended for both partners throughout treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests monitor blood cell levels, kidney, liver, and heart function. Disclose any liver or heart conditions, and all other medications, before commencing treatment, as interactions can affect Rubicyt's effectiveness. Inform your doctor if pregnant or breastfeeding.
Uses of Rubicyt 50mg Injection
Malignant neoplasm
Major Benefits of Rubicyt 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rubicyt 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Rubicyt 50mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Rubicyt 50mg Injection works:
Cytarabine 50mg injection is a chemotherapeutic agent targeting breast cancer. Its mechanism involves topoisomerase II inhibition, disrupting DNA replication in cancerous cells. Concurrent generation of cytotoxic free radicals further damages DNA, ultimately arresting tumor growth and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rubicyt 50mg Injection and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Rubicyt 50mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in potentially life-threatening circumstances where the physician judges the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Rubicyt 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Rubicyt 50mg Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Rubicyt 50mg Injection, can temporarily compromise the ability to drive safely.
KidneySAFE IF PRESCRIBED
Rubicyt 50mg Injection appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be evaluated.
LiverCAUTION
For individuals with liver impairment, Rubicyt 50mg Injection requires careful administration; dosage modification may be necessary. Physician consultation is advised. Rubicyt 50mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Rubicyt 50mg Injection :
NA
Facts to Know About Rubicyt 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently